Dermatology

LEO Pharma invests in biotech firm developing aerosol alopecia treatment deviceLEO Pharma is investing in biotechnology company Novpyxis, as it develops an aerosol-based drug delivery device used for topical skin treatments, according to a news release.
Earlier diagnosis of psoriatic arthritis will prevent disease progressionPsoriatic arthritis can often go undiagnosed in patients with psoriasis, and an earlier diagnosis is critical to prevent the adverse effects of psoriatic arthritis, according to an expert.
Acne, rosacea meds more expensive for Medicare patients seeing specialists
Acne, rosacea meds more expensive for Medicare patients seeing specialistsPatients on Medicare who receive prescriptions for acne and rosacea from specialists pay more for those medications than they would from a primary care physician, according to results of a new study.
Study associates adolescent acne with higher grades, possible future earningsAdolescents who have acne may have higher grade point averages and higher earning potential in the job market, according to findings from a recent study.
Growing pains in pediatric dermatology: Workforce shortage
Growing pains in pediatric dermatology: Workforce shortageUp to 30% of pediatric primary-care visits include a skin-related complaint, but the longstanding shortage of providers continues, thanks to a combination of factors
Novel acne gel found safe in three clinical trialsA nitric oxide-releasing gel to treat acne vulgaris has been found to be extremely safe, according to three Phase 1 pharmacokinetic clinical trials.
Isotretinoin study: Laser treatment safe one month post-treatmentA pilot study has successfully challenged the current non-evidenced medical recommendation that patients with acne scars should wait six to 12 months after completion of oral isotretinoin treatment before the safe initiation of nonablative fractional laser resurfacing.
Abatacept: Pricey, but Effective
Abatacept: Pricey, but EffectiveThe approval of abatacept (Orencia/Bristol-Myers Squibb) for psoriatic arthritis (PsA) earlier this month by the FDA offers a new treatment option for patients who are struggling to keep the disease under control.
Eric Schweiger, M.D., named award semifinalist
Eric Schweiger, M.D., named award semifinalistEric Schweiger, M.D., C.E.O., and founder of the Schweiger Dermatolo- gy Group, has been named a semifinalist for the EY Entrepreneur of the Year 2017 Award for the New York region, according to a news release.
CMS lowers estimates for MIPS compliance requirements
CMS lowers estimates for MIPS compliance requirementsThe Centers for Medicare and Medicaid Services (CMS) has notified more than 800,000 healthcare providers that they do not have to comply with the Merit-based Incentive Payment System in 2017.